PASSAGE BIO INC (PASG) Stock Fundamental Analysis

NASDAQ:PASG • US7027122099

8.8563 USD
+0.04 (+0.47%)
Last: Feb 18, 2026, 10:00 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, PASG scores 2 out of 10 in our fundamental rating. PASG was compared to 521 industry peers in the Biotechnology industry. While PASG seems to be doing ok healthwise, there are quite some concerns on its profitability. PASG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year PASG has reported negative net income.
  • In the past year PASG has reported a negative cash flow from operations.
  • In the past 5 years PASG always reported negative net income.
  • PASG had a negative operating cash flow in each of the past 5 years.
PASG Yearly Net Income VS EBIT VS OCF VS FCFPASG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • PASG has a Return On Assets (-61.04%) which is in line with its industry peers.
  • The Return On Equity of PASG (-145.45%) is worse than 63.34% of its industry peers.
Industry RankSector Rank
ROA -61.04%
ROE -145.45%
ROIC N/A
ROA(3y)-62.31%
ROA(5y)-54.67%
ROE(3y)-88.34%
ROE(5y)-72.01%
ROIC(3y)N/A
ROIC(5y)N/A
PASG Yearly ROA, ROE, ROICPASG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PASG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PASG Yearly Profit, Operating, Gross MarginsPASG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • PASG has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PASG has been increased compared to 5 years ago.
  • PASG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PASG Yearly Shares OutstandingPASG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
PASG Yearly Total Debt VS Total AssetsPASG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • PASG has an Altman-Z score of -14.22. This is a bad value and indicates that PASG is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -14.22, PASG is doing worse than 78.69% of the companies in the same industry.
  • PASG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.22
ROIC/WACCN/A
WACCN/A
PASG Yearly LT Debt VS Equity VS FCFPASG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that PASG has no problem at all paying its short term obligations.
  • PASG has a Current ratio of 2.51. This is in the lower half of the industry: PASG underperforms 70.25% of its industry peers.
  • PASG has a Quick Ratio of 2.51. This indicates that PASG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.51, PASG is doing worse than 68.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
PASG Yearly Current Assets VS Current LiabilitesPASG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.46% over the past year.
EPS 1Y (TTM)38.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PASG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.56% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y49.6%
EPS Next 2Y32.84%
EPS Next 3Y22.32%
EPS Next 5Y18.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PASG Yearly Revenue VS EstimatesPASG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
PASG Yearly EPS VS EstimatesPASG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • PASG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PASG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PASG Price Earnings VS Forward Price EarningsPASG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PASG Per share dataPASG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PASG's earnings are expected to grow with 22.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.84%
EPS Next 3Y22.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PASG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PASSAGE BIO INC

NASDAQ:PASG (2/18/2026, 10:00:43 AM)

8.8563

+0.04 (+0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-02
Inst Owners50.06%
Inst Owner Change-0.8%
Ins Owners0.2%
Ins Owner Change0.08%
Market Cap28.16M
Revenue(TTM)N/A
Net Income(TTM)-45.26M
Analysts85
Price Target40.39 (356.06%)
Short Float %0.36%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.46%
Min EPS beat(2)14.57%
Max EPS beat(2)28.35%
EPS beat(4)3
Avg EPS beat(4)10.06%
Min EPS beat(4)-6.56%
Max EPS beat(4)28.35%
EPS beat(8)6
Avg EPS beat(8)8.8%
EPS beat(12)8
Avg EPS beat(12)4.86%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-33.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.81%
EPS NY rev (1m)0%
EPS NY rev (3m)23.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-14.4
EYN/A
EPS(NY)-5.04
Fwd EYN/A
FCF(TTM)-10.53
FCFYN/A
OCF(TTM)-10.53
OCFYN/A
SpS0
BVpS9.79
TBVpS9.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.04%
ROE -145.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.31%
ROA(5y)-54.67%
ROE(3y)-88.34%
ROE(5y)-72.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z -14.22
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)49.41%
Cap/Depr(5y)403.88%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.65%
EPS Next Y49.6%
EPS Next 2Y32.84%
EPS Next 3Y22.32%
EPS Next 5Y18.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.53%
EBIT Next 3Y6.96%
EBIT Next 5Y23.29%
FCF growth 1Y59.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.56%
OCF growth 3YN/A
OCF growth 5YN/A

PASSAGE BIO INC / PASG FAQ

What is the fundamental rating for PASG stock?

ChartMill assigns a fundamental rating of 2 / 10 to PASG.


Can you provide the valuation status for PASSAGE BIO INC?

ChartMill assigns a valuation rating of 1 / 10 to PASSAGE BIO INC (PASG). This can be considered as Overvalued.


What is the profitability of PASG stock?

PASSAGE BIO INC (PASG) has a profitability rating of 0 / 10.


Can you provide the financial health for PASG stock?

The financial health rating of PASSAGE BIO INC (PASG) is 5 / 10.